Current Practices and Safety of Medication Use During Pediatric Rapid Sequence Intubation

Overview

Journal J Pediatr Pharmacol Ther

Specialty Pediatrics

Date 2024 Feb 9

PMID 38332961

Authors

Sarah A Bisesi

Sierra D Stauber

David J Hutchinson

Nicole M Acquisto

Affiliations

Soon will be listed here.

Abstract

Objectives: This study aimed to characterize medication-related practices during and immediately -following rapid sequence intubation (RSI) in pediatric care units across the United States and to evaluate adverse drug events.

Methods: This was a multicenter, observational study of medication practices surrounding intubation in pediatric and neonatal intensive care unit (NICU) and emergency department patients across the United States.

Results: A total of 172 patients from 13 geographically diverse institutions were included. Overall, 24%, 69%, and 50% received preinduction, induction, and neuromuscular blockade, respectively. Induction and neuromuscular blocking agent (NMBA) use was low in NICU patients (52% and 23%, respectively), whereas nearly all patients intubated outside of the NICU received both (98% and 95%, respectively). NICU patients who received RSI medications were older and weighed more. Despite infrequent use of atropine (21%), only 3 patients developed bradycardia after RSI. Of the 119 patients who received an induction agent, fentanyl (67%) and midazolam (34%) were administered most frequently. Hypotension and hypertension occurred in 23% and 24% of patients, respectively, but were not associated with a single induction agent. Etomidate use was low and not associated with development of adrenal insufficiency. Rocuronium was the most used NMBA (78%). Succinylcholine use was low (11%) and administered despite hyperkalemia in 2 patients. Postintubation sedation and analgesia were not used or inadequate based on timing of initiation in many patients who received a non-depolarizing NMBA.

Conclusions: Medication practices surrounding pediatric RSI vary across the United States and may be influenced by patient location, age, and weight.

References

Kovacich N, Nelson A, McCormick T, Kaucher K . Incidence of Bradycardia and the Use of Atropine in Pediatric Rapid Sequence Intubation in the Emergency Department. Pediatr Emerg Care. 2021; 38(2):e540-e543. DOI: 10.1097/PEC.0000000000002382. View

Fastle R, Roback M . Pediatric rapid sequence intubation: incidence of reflex bradycardia and effects of pretreatment with atropine. Pediatr Emerg Care. 2004; 20(10):651-5. DOI: 10.1097/01.pec.0000142947.35394.81. View

McPherson C, Miller S, El-Dib M, Massaro A, Inder T . The influence of pain, agitation, and their management on the immature brain. Pediatr Res. 2020; 88(2):168-175. PMC: 7223850. DOI: 10.1038/s41390-019-0744-6. View

Groth C, Acquisto N, Khadem T . Current practices and safety of medication use during rapid sequence intubation. J Crit Care. 2018; 45:65-70. DOI: 10.1016/j.jcrc.2018.01.017. View

Bruder E, Ball I, Ridi S, Pickett W, Hohl C . Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill patients. Cochrane Database Syst Rev. 2015; 1:CD010225. PMC: 6517008. DOI: 10.1002/14651858.CD010225.pub2. View

de Caen A, Berg M, Chameides L, Gooden C, Hickey R, Scott H . Part 12: Pediatric Advanced Life Support: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2015; 132(18 Suppl 2):S526-42. PMC: 6191296. DOI: 10.1161/CIR.0000000000000266. View

Mace S . Challenges and advances in intubation: rapid sequence intubation. Emerg Med Clin North Am. 2008; 26(4):1043-68, x. DOI: 10.1016/j.emc.2008.10.002. View

Foglia E, Ades A, Sawyer T, Glass K, Singh N, Jung P . Neonatal Intubation Practice and Outcomes: An International Registry Study. Pediatrics. 2018; 143(1). PMC: 6317557. DOI: 10.1542/peds.2018-0902. View

El-Orbany M, Connolly L . Rapid sequence induction and intubation: current controversy. Anesth Analg. 2010; 110(5):1318-25. DOI: 10.1213/ANE.0b013e3181d5ae47. View

10.

Zelicof-Paul A, Smith-Lockridge A, Schnadower D, Tyler S, Levin S, Roskind C . Controversies in rapid sequence intubation in children. Curr Opin Pediatr. 2005; 17(3):355-62. DOI: 10.1097/01.mop.0000162365.64140.b7. View

11.

Kendrick D, Monroe K, Bernard D, Tofil N . Sedation after intubation using etomidate and a long-acting neuromuscular blocker. Pediatr Emerg Care. 2009; 25(6):393-6. DOI: 10.1097/PEC.0b013e3181a7923b. View

12.

Pappal R, Roberts B, Mohr N, Ablordeppey E, Wessman B, Drewry A . The ED-AWARENESS Study: A Prospective, Observational Cohort Study of Awareness With Paralysis in Mechanically Ventilated Patients Admitted From the Emergency Department. Ann Emerg Med. 2021; 77(5):532-544. PMC: 8166299. DOI: 10.1016/j.annemergmed.2020.10.012. View

13.

Ozawa Y, Ades A, Foglia E, DeMeo S, Barry J, Sawyer T . Premedication with neuromuscular blockade and sedation during neonatal intubation is associated with fewer adverse events. J Perinatol. 2019; 39(6):848-856. DOI: 10.1038/s41372-019-0367-0. View

14.

Park R, Peyton J, Kovatsis P . Neonatal Airway Management. Clin Perinatol. 2019; 46(4):745-763. DOI: 10.1016/j.clp.2019.08.008. View

15.

Simon L, Trifa M, Mokhtari M, Hamza J, Treluyer J . Premedication for tracheal intubation: a prospective survey in 75 neonatal and pediatric intensive care units. Crit Care Med. 2004; 32(2):565-8. DOI: 10.1097/01.CCM.0000108883.58081.E3. View